Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

Immunis, Inc., a clinical-stage biotech developing novel secretomes for age-related diseases and immune dysfunction, has ...

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

Parkinson's disease (PD) and Alzheimer's disease (AD) are examples of brain illnesses that begin to develop in patients far ...

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

The initial phases of their research, involving experiments with mice and brain models, might take several years, Tesar said.

"That discovery indicates a broader scientific value to this research, including potential clinical applications." Dr. Zubair has launched stem cell experiments from his lab on three different ...

Electro-acupuncture may help manage obesity by reducing osteoprotegerin, a protein tied to fat cell growth. This TCM approach ...

Radiopharmaceuticals are injectable drugs containing radioisotopes, the radioactive forms of elements, that directly attack ...

biomodal, an omics-based life sciences technology and analytics company, today announced it will present new data highlighting the utility of duet mul ...

Jason Gerberry, an analyst from Bank of America Securities, reiterated the Sell rating on Galapagos (GLPG – Research Report). The ...